- Home
- DLTH vs GNLX Comparison
DLTH vs GNLX Comparison
Compare DLTH & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DLTH | GNLX |
|---|---|---|
| Founded | 1989 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 113.6M |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DLTH | GNLX |
|---|---|---|
| Price | $3.08 | $2.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $19.80 |
| AVG Volume (30 Days) | ★ 579.3K | 154.8K |
| Earning Date | 03-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 64.12 | 9.47 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $565,184,000.00 | $8,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $1.99 |
| 52 Week High | $4.66 | $8.54 |
Technical Indicators
Market Signals| Indicator | DLTH | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.46 | 47.92 |
| Support Level | $2.05 | $2.54 |
| Resistance Level | $3.31 | $3.00 |
| Average True Range (ATR) | 0.20 | 0.16 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 79.92 | 52.00 |
Price Performance
Historical ComparisonAbout DLTH Duluth Holdings Inc. Class B
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.